US Patent Issued to Helio Health, The Regents of the University of California on July 8 for "Colon cancer methylation markers and uses thereof" (Chinese, American Inventors)

ALEXANDRIA, Va., July 9 -- United States Patent no. 12,351,876, issued on July 8, was assigned to Helio Health Inc. (Irvine, Calif.) and The Regents of the University of California (Oakland, Calif.).

"Colon cancer methylation markers and uses thereof" was invented by Kang Zhang (San Diego), Rui Hou (Shenyang, China) and Lianghong Zheng (Shenyang, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein are methods and kits for identifying a subject as having colon cancer. Also provided herein are methods and kits for determining the prognosis of a subject having colon cancer and for determining the progression of colon cancer in a subject."

The patent was filed on July 6, 2017, under Applicatio...